Skip to main content

Med BioGene Taps JRG for Strategic Advice to Help Launch Cancer Dx

NEW YORK (GenomeWeb News) — Med BioGene said today that it has hired JRG Ventures for strategic business advice as it moves to commercialize a new genomic-based diagnostic test for lymphoma.
 
JRG will help the company define its partnering and commercialization strategy as it prepares to roll out its clinical laboratory LymphExpress Dx test.
 
JRG advises companies involved in life sciences, healthcare, and information technology, partnering, licensing, corporate and regulatory strategies, and operations and logistics.
 
Financial terms of the agreement were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.